PEN: Penumbra Inc

PEN新闻

• 15:07 AngioDynamics: Growth Is Working, Price Knows It (Downgrade) (NASDAQ:ANGO)
• 15:40 IQV vs. PEN: Which Stock Is the Better Value Option?
• 05:15 Tactile Systems Stock: Clean Balance Sheet, But A Possible Value Trap (NASDAQ:TCMD)
• 15:59 Boston Scientific: The Time Has Come To Catch This Falling Knife (NYSE:BSX)
• 15:40 GMED vs. PEN: Which Stock Should Value Investors Buy Now?
• 16:47 Penumbra Receives CE Nod for THUNDERBOLT: Stock to Gain?
• 10:36 ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
• 15:40 GMED or PEN: Which Is the Better Value Stock Right Now?
• 15:30 Why Is Penumbra (PEN) Down 1.2% Since Last Earnings Report?
• 19:16 Baron Health Care Fund Q1 2026 Portfolio Activity
• 03:25 Diamond Hill Long-Short Strategy Q1 2026 Portfolio Movers: Gains, Drags, And Trades
• 21:25 Penumbra (PEN) Misses Q1 Earnings Estimates
• 15:40 ALC vs. PEN: Which Stock Should Value Investors Buy Now?
• 07:00 NovoCure Stock Shows Strength With RS Upgrade; Investors Should Watch For Next Entry
• 16:45 3 Reasons Why Penumbra (PEN) Is a Great Growth Stock
• 02:10 Riverwater Small Cap Strategy: Q1 2026 Buys, Sells, And Standouts
• 13:45 Here's Why Penumbra (PEN) is a Strong Growth Stock
• 16:45 3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
• 15:30 Penumbra (PEN) Down 1.6% Since Last Earnings Report: Can It Rebound?
• 12:49 Reasons to Retain Penumbra Stock in Your Portfolio for Now
• 13:10 Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates
• 16:45 Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"
• 13:37 瑞银重申Penumbra股票评级,对血栓切除术市场持乐观态度
• 13:32 UBS reiterates Penumbra stock rating on thrombectomy confidence